ID

34594

Description

Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT00943917

Link

https://clinicaltrials.gov/show/NCT00943917

Keywords

  1. 1/19/19 1/19/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 19, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Type 2 Diabetes NCT00943917

Eligibility Type 2 Diabetes NCT00943917

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
males or females age 18-70 years
Description

ID.1

Data type

boolean

type 2 diabetes mellitus for ≥ 6 months prior to screening visit 1
Description

ID.2

Data type

boolean

on a stable (> 3 months prior to screening visit 1) treatment regimen of metformin monotherapy;
Description

ID.3

Data type

boolean

fasting plasma glucose < 240 mg/dl at screening visit 1
Description

ID.4

Data type

boolean

hba1c ≥ 7% and ≤ 10% at screening visit 1
Description

ID.5

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior treatment with exenatide
Description

ID.6

Data type

boolean

treatment with any of the following antidiabetic agents within 3 months prior to screening visit 1: tzds, sulfonylureas, dpp iv inhibitors, acarbose, or insulin (injected or inhaled)
Description

ID.7

Data type

boolean

history of type 1 diabetes and/or history of diabetic ketoacidosis
Description

ID.8

Data type

boolean

body mass index ≥ 40 kg/m2;
Description

ID.9

Data type

boolean

history of organ transplantation
Description

ID.10

Data type

boolean

Similar models

Eligibility Type 2 Diabetes NCT00943917

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
males or females age 18-70 years
boolean
ID.2
Item
type 2 diabetes mellitus for ≥ 6 months prior to screening visit 1
boolean
ID.3
Item
on a stable (> 3 months prior to screening visit 1) treatment regimen of metformin monotherapy;
boolean
ID.4
Item
fasting plasma glucose < 240 mg/dl at screening visit 1
boolean
ID.5
Item
hba1c ≥ 7% and ≤ 10% at screening visit 1
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
prior treatment with exenatide
boolean
ID.7
Item
treatment with any of the following antidiabetic agents within 3 months prior to screening visit 1: tzds, sulfonylureas, dpp iv inhibitors, acarbose, or insulin (injected or inhaled)
boolean
ID.8
Item
history of type 1 diabetes and/or history of diabetic ketoacidosis
boolean
ID.9
Item
body mass index ≥ 40 kg/m2;
boolean
ID.10
Item
history of organ transplantation
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial